We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $129.74 · 27 analysts
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Stored first · Google News · Yahoo Finance (English)
Norges Bank Purchases New Holdings in Merck & Co., Inc. $MRK - MarketBeat
Norges Bank Purchases New Holdings in Merck & Co., Inc. $MRK MarketBeat
Savant Capital LLC Has $9.29 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Savant Capital LLC Has $9.29 Million Stock Position in Merck & Co., Inc. $MRK MarketBeat
Forsta AP Fonden Lowers Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Forsta AP Fonden Lowers Stock Holdings in Merck & Co., Inc. $MRK MarketBeat
Eurizon Capital SGR S.p.A. Purchases New Position in Merck & Co., Inc. $MRK - MarketBeat
Eurizon Capital SGR S.p.A. Purchases New Position in Merck & Co., Inc. $MRK MarketBeat
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 04. | After market close (AMC) | $-0.15 | — | — | $16.39B | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $2.01 | — | — | $15.53B | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $5.26 | — | — | $48.54B | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $4.02 | — | — | $31.89B | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 01. | Wells Fargo | — | Maintain | Overweight → Overweight | — | Wells Fargo: Overweight |
| 2026. 04. 14. | UBS | — | Maintain | Buy → Buy | — | UBS: Buy |
| 2026. 04. 07. | JP Morgan | — | Maintain | Overweight → Overweight | — | JP Morgan: Overweight |
| 2026. 03. 31. | RBC Capital | — | Maintain | Outperform → Outperform | — | RBC Capital: Outperform |
| 2026. 03. 21. | Citigroup | — | Maintain | Neutral → Neutral | — | Citigroup: Neutral |
| 2026. 03. 12. | Wells Fargo | — | Maintain | Overweight → Overweight | — | Wells Fargo: Overweight |
As of FY2026Q1 · Source: SEC/DART + price data
No holdings data to show.